$TPIV Closed Up 38.1%!
October 5th, 2009 at 2:03 pm Posted by The Dean
The Dean worked overtime this weekend to teach the entire CollegeStock Community about $TPIV.
If you did your homework this weekend, you’d already know that TapImmune Inc. (OTC: TPIV) is a biotechnology company that specializes in innovative therapies and vaccines for cancer and infectious diseases. $TPIV’s leading product is the TAP vaccine which acts as a marker to identify and kills cancer cells.
All of The Dean’s students are important to him and that’s why he wanted the CollegeStock Community to study up this weekend. The Dean taught everyone about $TPIV because he saw the profit potential in their patented line of cancer and infectious disease fighting products.
$TPIV closed up 38.1% at $1.45 and hit for a high of $1.48 for a potential profit of 40.9%—which means $TPIV could very well move into Ivy League territory.
$TPIV traded over 1 million shares today—more than the past 3 months of trading activity combined. The Dean thinks today’s trading volume may lead to further excitement about $TPIV, which could mean more gains.
Will you make The Dean’s List this quarter? The only way to win $5,000 of The Dean’s money is to register for The Dean’s Honors Class and become eligible for The CollegeStock Scholarship Fund.
perhaps you should have given this pick to your paid members while the market was still open on Friday…
You’re right Pack but I was thinking maybe he didn’t have the pick?